Toward clinical translation of biosensors for chronic kidney disease
Biosensors and Bioelectronics · 2026-03 · 296 · 118328
DOI: 10.1016/j.bios.2025.118328 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biosensors and Bioelectronics, 2026-03. Verfasst von Ronil J Rath und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemical and Biomolecular Engineering, The University of Sydney, Sydney, NSW, 2006, Australia; The University of Sydney, Sydney Nano Instit…. Hauptthemen laut MEDLINE: Biosensing Techniques, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 118 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Australian Research Council.
Abstract (Originalsprache)
Chronic kidney disease (CKD) is a progressive disorder that affects one in ten individuals globally and ranks as the seventh leading cause of mortality. Its rising prevalence, driven by lifestyle factors and ultra-processed diets, underscores the need for prevention and early detection. Current assessments of kidney function are invasive, time-consuming, and centralized, thus limiting scalability and accessibility. Point-of-care and wearable biosensors offer a paradigm shift by enabling decentralized, real-time monitoring; however, their clinical translation remains challenging. This review provides a roadmap for advancing CKD biosensor research toward clinical implementation. We examine (i) key biomarkers and risk factors for early detection, (ii) their partitioning in alternative body fluids such as sweat, interstitial fluid, saliva, and tears, (iii) sensor technologies validated through animal and human proof-of-concept studies. Beyond technical aspects, we highlight strategies for navigating institutional review boards, securing ethics approval, and designing clinical trials tailored to CKD biosensors. Finally, we discuss current challenges, opportunities, and future directions, offering practical guidance for integrating these technologies into clinical workflows.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Chemical and Biomolecular Engineering, The University of Sydney, Sydney, NSW, 2006, Australia; The University of Sydney, Sydney Nano Institute, Sydney, NSW, 2006, Australia; Department of Biochemistry and Chem…
- School of Chemical and Biomolecular Engineering, The University of Sydney, Sydney, NSW, 2006, Australia; The University of Sydney, Sydney Nano Institute, Sydney, NSW, 2006, Australia.
- Department of Electrical and Computer Engineering, Rice University, Houston, TX, 77005, USA.
- Aiiso Yufeng Li Family Department of Chemical and Nanoengineering, University of California San Diego, La Jolla, CA, 92093, USA.
- Institute of Translational Medicine, ETH Zurich, 8093, Zurich, Switzerland. Electronic address: nbrasier@ethz.ch.
- Division of Physical Science and Center of Excellence for Trace Analysis and Biosensor, Prince of Songkla University, Hat Yai, 90110, Songkhla, Thailand.
Förderung
- Australian Research Council
Zitieren
APA
Rath, R. J., Talebian, S., Mayol, B., Ding, S., Brasier, N., Jeerapan, I., Sempionatto, J. R., Naficy, S., & Silva, S. M. (2026). Toward clinical translation of biosensors for chronic kidney disease. Biosensors and Bioelectronics, 296, 118328. https://doi.org/10.1016/j.bios.2025.118328
Vancouver
Rath RJ, Talebian S, Mayol B, Ding S, Brasier N, Jeerapan I, et al. Toward clinical translation of biosensors for chronic kidney disease. Biosensors and Bioelectronics. 2026;296:118328. doi:10.1016/j.bios.2025.118328
BibTeX
@article{Rath2026,
author = {Rath, Ronil J and Talebian, Sepehr and Mayol, Beatriz and Ding, Shichao and Brasier, Noé and Jeerapan, Itthipon and Sempionatto, Juliane R and Naficy, Sina and Silva, Saimon M},
title = {Toward clinical translation of biosensors for chronic kidney disease},
journal = {Biosensors and Bioelectronics},
year = {2026},
volume = {296},
pages = {118328},
doi = {10.1016/j.bios.2025.118328}
}
EUVIMED